These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24847271)

  • 1. The battle of Alzheimer's Disease - the beginning of the future Unleashing the potential of academic discoveries.
    Lundkvist J; Halldin MM; Sandin J; Nordvall G; Forsell P; Svensson S; Jansson L; Johansson G; Winblad B; Ekstrand J
    Front Pharmacol; 2014; 5():102. PubMed ID: 24847271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of comprehensive Alzheimer's disease centers to address unmet national needs.
    Trojanowski JQ; Arnold SE; Karlawish JH; Brunden K; Cary M; Davatzikos C; Detre J; Gaulton G; Grossman M; Hurtig H; Jedrziewski K; McCluskey L; Naylor M; Polsky D; Schellenberg GD; Siderowf A; Shaw LM; Van Deerlin V; Wang LS; Werner R; Xie SX; Lee VM
    Alzheimers Dement; 2010 Mar; 6(2):150-5. PubMed ID: 20298979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Alzheimer's disease: the next 10 years.
    Hampel H; Prvulovic D; Teipel S; Jessen F; Luckhaus C; Frölich L; Riepe MW; Dodel R; Leyhe T; Bertram L; Hoffmann W; Faltraco F;
    Prog Neurobiol; 2011 Dec; 95(4):718-28. PubMed ID: 22137045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2021 Alzheimer's disease facts and figures.
    Alzheimers Dement; 2021 Mar; 17(3):327-406. PubMed ID: 33756057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug repositioning: an opportunity to develop novel treatments for Alzheimer's disease.
    Corbett A; Williams G; Ballard C
    Pharmaceuticals (Basel); 2013 Oct; 6(10):1304-21. PubMed ID: 24275851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mary S. Easton Center of Alzheimer's Disease Research at UCLA: advancing the therapeutic imperative.
    Cummings JL; Ringman J; Metz K
    J Alzheimers Dis; 2010; 19(2):375-88. PubMed ID: 20110588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strengthening the Case for Epilepsy Drug Development: Bridging Experiences from the Alzheimer's Disease Field-An Opinion.
    Twyman RE
    Neurochem Res; 2017 Jul; 42(7):2099-2115. PubMed ID: 28589521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing Trials of Disease Modifying Agents for Early and Preclinical Alzheimer's Disease Intervention: What Evidence is Meaningful to Patients, Providers, and Payers?
    Messner DA; Rabins P; Downing AC; Irizarry M; Foster NL; Al Naber J; Dabbous O; Fillit H; Gabler S; Krakauer R; Lotz D; Payzant E; Schneider L; Tyrone J; Van Amerongen D; Wuest D
    J Prev Alzheimers Dis; 2019; 6(1):20-26. PubMed ID: 30569082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of interventions for the secondary prevention of Alzheimer's dementia: the European Prevention of Alzheimer's Dementia (EPAD) project.
    Ritchie CW; Molinuevo JL; Truyen L; Satlin A; Van der Geyten S; Lovestone S;
    Lancet Psychiatry; 2016 Feb; 3(2):179-86. PubMed ID: 26683239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current topics about mild cognitive impairment (MCI)].
    Yamamoto Y
    Seishin Shinkeigaku Zasshi; 2011; 113(6):584-92. PubMed ID: 21815470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2023 Alzheimer's disease facts and figures.
    Alzheimers Dement; 2023 Apr; 19(4):1598-1695. PubMed ID: 36918389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease.
    Bennett DA; Yu L; De Jager PL
    Biochem Pharmacol; 2014 Apr; 88(4):617-30. PubMed ID: 24508835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2022 Alzheimer's disease facts and figures.
    Alzheimers Dement; 2022 Apr; 18(4):700-789. PubMed ID: 35289055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Japan-China Joint Medical Workshop on Drug Discoveries and Therapeutics 2008: The need of Asian pharmaceutical researchers' cooperation.
    Nakata M; Tang W
    Drug Discov Ther; 2008 Oct; 2(5):262-3. PubMed ID: 22504718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex and gender considerations in Alzheimer's disease: The Women's Brain Project contribution.
    Castro-Aldrete L; Moser MV; Putignano G; Ferretti MT; Schumacher Dimech A; Santuccione Chadha A
    Front Aging Neurosci; 2023; 15():1105620. PubMed ID: 37065460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the prevention of Alzheimer's Disease.
    Sindi S; Mangialasche F; Kivipelto M
    F1000Prime Rep; 2015; 7():50. PubMed ID: 26097723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Genetics in Advancing Precision Medicine for Alzheimer's Disease-A Narrative Review.
    Freudenberg-Hua Y; Li W; Davies P
    Front Med (Lausanne); 2018; 5():108. PubMed ID: 29740579
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.